Tags |
|
|
Links |
|
|
Advice Pool - Drug Abuse Treatment Programs
There are about 10,000 drug rehabilitation and treatment centers in the country today. And each one may u
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
se varying programs to deal with addiction. But generally, drug addiction treatments are grouped into thr
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
ee categories.
Kinds of Treatments
Addicts of certain substances can be treated in outpatient settings.
Kinds of Treatments
Addicts of certain substances can be treated in outpatient settings.
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
Patients are subjected to methadone, a medication taken orally. Methadone suppresses cravings and prevent
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
s withdrawal symptoms from surfacing. With sustained dosage, a person can be stabilized and can function
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
ormally.
This is the first step taken to prepare a patient for counseling and further treatments. With t
This is the first step taken to prepare a patient for counseling and further treatments. With t
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
he medication, a patient can be more receptive to interventions such as physiotherapies and group counsel
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ing.
The second kind of treatment involves a medication called naltrexone. The medication is administere
The second kind of treatment involves a medication called naltrexone. The medication is administere
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
after detoxification of the patient in a residential setting. This is to prevent withdrawal syndrome in
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
the patient. A patient takes this drug orally daily or thrice a week, depending on the prescription of hi
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
physician. The drug inhibits cravings for addictive drugs. But in order for this medication to work, sus
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
tained counseling is needed.
For people with graver conditions or who have been abusing drugs for a long
For people with graver conditions or who have been abusing drugs for a long
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
time, residential treatment is needed. This involves admitting a patient in a facility for 6 to 12 month
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
to address the problem. These facilities provide an atmosphere of a home rather than that of a hospital.
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
Modern-day residential treatment employs many models of rehabilitation: from the therapeutic community
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
o cognitive-behavioral therapies. These treatments involve medication as well as counseling available 24
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
hours a day. This arrangement works better for most patients who may need a fresh environment- away from
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
his natural surroundings to work on his rehabilitation. Other patients also form a support group- enhanci
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
g counseling sessions.
But whatever forms of treatment a patient chooses to go through, continued counse
But whatever forms of treatment a patient chooses to go through, continued counse
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
ling and assistance from professionals and family are needed to ensure sustained recovery form drug abuse
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.advicepool.org.ua/article/243154/advicepool-Drug-Abuse-Treatment-Programs.html">Drug Abuse Treatment Programs</a>
BB link (for phorums):
[url=http://www.advicepool.org.ua/article/243154/advicepool-Drug-Abuse-Treatment-Programs.html]Drug Abuse Treatment Programs[/url]
Related Articles:
Business Success: Luck or Hard Work?
Getting Ready with Affiliate Marketing
Bookmark it:
|